Bookmark Article
Takeda Plans to Launch Dengue Vaccine in India
Takeda is set to launch its dengue vaccine, Qdenga, in India next year, partnering with Biological E to support the ‘Make-in-India’ initiative. The company will implement a tiered pricing model to improve accessibility and is currently navigating regulatory processes, anticipating licensing by 2026. This collaboration aims to enhance public health response to dengue in India, ensuring that the vaccine is both affordable and readily available to those in need.
Full Article
